Insitro, which uses machine learning to speed-up drug discovery, raises $400M, led by Canada Pension Plan; other investors include SoftBank, Temasek, a16z, more — Start-up run by former Stanford professor uses AI to analyse human genetics and work out where to target drugs
Insitro, Which Uses Machine Learning To Speed-Up Drug Discovery, Raises $400M, Led By Canada Pension Plan; Other Investors Include SoftBank, Temasek, A16z, More (Hannah Kuchler/Financial Times)
By uzair
uzair
Uzair is a features writer at Cafeer.de. He is a graduate of Emerson College and recently completed the MFA in writing.
Add A Comment